Cytoskeletal proteins: hidden targets of cytoprotective signaling?
Tetsuji
T
Miura
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D019610:Cytoprotection; D003931:Diacetyl / Q000031:analogs & derivatives* / Q000494:pharmacology; D016189:Dystrophin / Q000378:metabolism*; D004789:Enzyme Activation; D006801:Humans; D057775:Ischemic Postconditioning; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000201:enzymology / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D015428:Myocardial Reperfusion Injury / Q000201:enzymology / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D009206:Myocardium / Q000201:enzymology* / Q000473:pathology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D021381:Protein Transport; D012508:Sarcolemma / Q000201:enzymology; D015398:Signal Transduction / Q000187:drug effects; D013997:Time Factors; D016277:Ventricular Function, Left / Q000187:drug effects
D016189:Dystrophin; C004717:diacetylmonoxime; D000255:Adenosine Triphosphate; D019869:Phosphatidylinositol 3-Kinases; D003931:Diacetyl